Home NDC 60429-175 CITALOPRAM
Product NDC 60429-175
11-digit product format 604290175
Labeler code 60429
Product ID 60429-175_2bb26393-e61c-3ff0-e063-6394a90aea5e
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name citalopram
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Golden State Medical Supply, Inc.
Application ANDA077045
Marketing category ANDA
Marketing start 2005-04-29
Substance CITALOPRAM HYDROBROMIDE
Active strength 40 mg/1
Pharmacologic classes Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A077045-001 CITALOPRAM HYDROBROMIDE CITALOPRAM HYDROBROMIDE EQ 40MG BASE TABLET / ORAL AB 2005-04-29 A077045-002 CITALOPRAM HYDROBROMIDE CITALOPRAM HYDROBROMIDE EQ 20MG BASE TABLET / ORAL AB 2005-04-29 A077045-003 CITALOPRAM HYDROBROMIDE CITALOPRAM HYDROBROMIDE EQ 10MG BASE TABLET / ORAL AB 2005-04-29
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 123 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A077045-001 CITALOPRAM HYDROBROMIDE EQ 40MG BASE TABLET / ORAL AB 2005-04-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A077045-002 CITALOPRAM HYDROBROMIDE EQ 20MG BASE TABLET / ORAL AB 2005-04-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A077045-003 CITALOPRAM HYDROBROMIDE EQ 10MG BASE TABLET / ORAL AB 2005-04-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077045-001 CITALOPRAM HYDROBROMIDE EQ 40MG BASE TABLET / ORAL AB 2005-04-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077045-002 CITALOPRAM HYDROBROMIDE EQ 20MG BASE TABLET / ORAL AB 2005-04-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077045-003 CITALOPRAM HYDROBROMIDE EQ 10MG BASE TABLET / ORAL AB 2005-04-29 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A077045-001 CITALOPRAM HYDROBROMIDE EQ 40MG BASE TABLET / ORAL AB 2005-04-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A077045-002 CITALOPRAM HYDROBROMIDE EQ 20MG BASE TABLET / ORAL AB 2005-04-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A077045-003 CITALOPRAM HYDROBROMIDE EQ 10MG BASE TABLET / ORAL AB 2005-04-29 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A077045-001 CITALOPRAM HYDROBROMIDE EQ 40MG BASE TABLET / ORAL AB 2005-04-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A077045-002 CITALOPRAM HYDROBROMIDE EQ 20MG BASE TABLET / ORAL AB 2005-04-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A077045-003 CITALOPRAM HYDROBROMIDE EQ 10MG BASE TABLET / ORAL AB 2005-04-29 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A077045-001 CITALOPRAM HYDROBROMIDE EQ 40MG BASE TABLET / ORAL AB 2005-04-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A077045-002 CITALOPRAM HYDROBROMIDE EQ 20MG BASE TABLET / ORAL AB 2005-04-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A077045-003 CITALOPRAM HYDROBROMIDE EQ 10MG BASE TABLET / ORAL AB 2005-04-29 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A077045-001 CITALOPRAM HYDROBROMIDE EQ 40MG BASE TABLET / ORAL AB 2005-04-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A077045-002 CITALOPRAM HYDROBROMIDE EQ 20MG BASE TABLET / ORAL AB 2005-04-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A077045-003 CITALOPRAM HYDROBROMIDE EQ 10MG BASE TABLET / ORAL AB 2005-04-29 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A077045-001 CITALOPRAM HYDROBROMIDE EQ 40MG BASE TABLET / ORAL AB 2005-04-29 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A077045-002 CITALOPRAM HYDROBROMIDE EQ 20MG BASE TABLET / ORAL AB 2005-04-29 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A077045-003 CITALOPRAM HYDROBROMIDE EQ 10MG BASE TABLET / ORAL AB 2005-04-29 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A077045-001 CITALOPRAM HYDROBROMIDE EQ 40MG BASE TABLET / ORAL AB 2005-04-29 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A077045-002 CITALOPRAM HYDROBROMIDE EQ 20MG BASE TABLET / ORAL AB 2005-04-29 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A077045-003 CITALOPRAM HYDROBROMIDE EQ 10MG BASE TABLET / ORAL AB 2005-04-29 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A077045-001 CITALOPRAM HYDROBROMIDE EQ 40MG BASE TABLET / ORAL AB 2005-04-29 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A077045-002 CITALOPRAM HYDROBROMIDE EQ 20MG BASE TABLET / ORAL AB 2005-04-29 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A077045-003 CITALOPRAM HYDROBROMIDE EQ 10MG BASE TABLET / ORAL AB 2005-04-29 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A077045-001 CITALOPRAM HYDROBROMIDE EQ 40MG BASE TABLET / ORAL AB 2005-04-29 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A077045-002 CITALOPRAM HYDROBROMIDE EQ 20MG BASE TABLET / ORAL AB 2005-04-29 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A077045-003 CITALOPRAM HYDROBROMIDE EQ 10MG BASE TABLET / ORAL AB 2005-04-29 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A077045-001 CITALOPRAM HYDROBROMIDE EQ 40MG BASE TABLET / ORAL AB 2005-04-29 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A077045-002 CITALOPRAM HYDROBROMIDE EQ 20MG BASE TABLET / ORAL AB 2005-04-29 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A077045-003 CITALOPRAM HYDROBROMIDE EQ 10MG BASE TABLET / ORAL AB 2005-04-29 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A077045-001 CITALOPRAM HYDROBROMIDE EQ 40MG BASE TABLET / ORAL AB 2005-04-29 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A077045-002 CITALOPRAM HYDROBROMIDE EQ 20MG BASE TABLET / ORAL AB 2005-04-29 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A077045-003 CITALOPRAM HYDROBROMIDE EQ 10MG BASE TABLET / ORAL AB 2005-04-29 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A077045-001 CITALOPRAM HYDROBROMIDE EQ 40MG BASE TABLET / ORAL AB 2005-04-29 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A077045-002 CITALOPRAM HYDROBROMIDE EQ 20MG BASE TABLET / ORAL AB 2005-04-29 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A077045-003 CITALOPRAM HYDROBROMIDE EQ 10MG BASE TABLET / ORAL AB 2005-04-29 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A077045-001 CITALOPRAM HYDROBROMIDE EQ 40MG BASE TABLET / ORAL AB 2005-04-29 8072bd15b7f6…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 123 observed states.
Additional Listing Data#
Finished product Yes
Brand name base CITALOPRAM
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength CITALOPRAM HYDROBROMIDE 40 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination I1E9D14F36 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 3 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 200371 Internal RxNorm lookup 283672 Internal RxNorm lookup 309314 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 60429-175-01 CITALOPRAM 100 in 1 BOTTLE TABLET, FILM COATED 100 13 60429-175-10 CITALOPRAM 1000 in 1 BOTTLE TABLET, FILM COATED 1000 13 60429-175-30 CITALOPRAM 30 in 1 BOTTLE TABLET, FILM COATED 30 13
DailyMed Socrata Ingredients# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 60429-175 CITALOPRAM TABLET, FILM COATED [GOLDEN STATE MEDICAL SUPPLY, INC.] 13 Current NDC, Legacy NDC, 3 package rows 20250119_f3a26d92-b662-4896-82eb-261948042408.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join CITALOPRAM CITALOPRAM Golden State Medical Supply, Inc. f3a26d92-b662-4896-82eb-261948042408 2025-01-14 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 077045 application number: ANDA077045 ndc (product): 60429-175 CITALOPRAM CITALOPRAM Epic Pharma, LLC 08b6d5da-5919-4760-9e16-3b478a14d6d7 2024-09-18 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 077045 application number: ANDA077045 Citalopram CITALOPRAM Aphena Pharma Solutions - Tennessee, LLC 3d70380f-ef97-4de9-a8f8-44ef9ba7e5a7 2020-05-13 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 077045 application number: ANDA077045
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 60429-175-01 60429017501 100 TABLET, FILM COATED in 1 BOTTLE (60429-175-01) 2011-05-20 0000-00-00 No No Current 60429-175-10 60429017510 1000 TABLET, FILM COATED in 1 BOTTLE (60429-175-10) 2011-05-20 0000-00-00 No No Current 60429-175-30 60429017530 30 in 1 BOTTLE Historical